Drug scandal brings bad name to Games

Wednesday 14, Jul 2010

admin

Drug scandal brings bad name to GamesThe first drug scandal of the Paralympics rocked the Beijing Olympics but things soon start going the right way as “Blade Runner” Oscar Pistorius created headlines with a thrilling 100m track win.

Pistorius crossed the line in 11.17sec at the Bird’s Nest National Stadium on a wet night, an event that was also highlighted by Marlon Shirley failing to materialize by collapsing two-thirds into the race.

From Foxsports.com.au:

Earlier a shadow was cast over the Games when it was revealed that Pakistani power lifter Naveed Ahmed Butt, 37, had been given a two-year ban for steroid use.

In the first drugs scandal of the Paralympics, he tested positive for the steroid methandienone metabolites on September 4, two days before the opening ceremony, the International Paralympic Committee said.

“In accordance with the IPC anti-doping code, and after a hearing of the IPC anti-doping committee, the IPC ratified the decision to disqualify Butt,” the committee said in a statement.

A total of 356 tests have been carried out at the Games, both in and out of competition, according to IPC figures until the end of Monday.

At the Athens Games in 2004, 680 doping tests were conducted, resulting in 10 anti-doping rule violations, according to the IPC.

In other news Heath Francis pulled off Australia’s first gold medal in the 200m sprint, winning in world record time in his T46 class.

The one-armed runner finished well clear of the field in a time of 21.74sec over Cyprus silver medallist Antonis Aresti and Cuba’s Ettiam Calderon in third.

Naveed Ahmed Butt, power lifter from Pakistan, was rendered disqualified by the International Paralympic Committee in accordance with the IPC anti-doping code and a hearing of the IPC anti-doping committee.

OTC Topical steroid sale may be approved by the FDA

Saturday 19, Jun 2010

admin

OTC Topical steroid sale may be approved by the FDAPsoriasis Cure Now, a nonprofit patient advocacy group, has urged a joint hearing of two Food and Drug Administration Advisory Committees for approving the over-the-counter (OTC) sale of specific topical steroids that presently require a prescription.

Topical corticosteroids play a big role for treating psoriasis patients all over the world and approximately 6.5 million people in the United States alone. The advocacy group remarked that OTC status of these steroids can help in reducing medical costs and provide improved comfort.

From Medicalnewstoday.com:

Topical steroids come in dozens of variations in drug type and strength. One common classification system lists seven steroid potencies from mild to ultra high, with each of the seven classes offering numerous choices. For about 15 years, the strongest steroid available without a prescription has been hydrocortisone 1%, a very mild formulation.

In its statement to the FDA, the group called for better labeling and other education efforts both for patients and physicians about topical steroids and their potential side effects, and recommended particularly close attention to topical steroid use by pediatric psoriasis patients.

“While we believe additional steroids should be available OTC, we urge the FDA to weight carefully how best to educate parents who face difficult choices about how, and how aggressively, to treat psoriasis in their children,” Paranzino added. “Topical steroids play a role in treating many children with psoriasis, but there are non-steroid alternatives that should also be considered.”

Michael Paranzino, President of Psoriasis Cure Now, said that certain topical steroids require a prescription and can be safely used by psoriasis patients in an OTC setting.

The World of Anabolic Steroids

Thursday 03, Jun 2010

admin

The World of Anabolic SteroidsAnabolic steroids are used by sportsmen, especially bodybuilders and strength athletes, to build solid muscles in short time. They are synthetic hormones capable of promoting the processes of protein retention and tissue growth.

But use of steroids can result in side effects when they are abused or of a low quality and these side effects may vary from depression to psychological changes and from increased aggression to infertility.

From Topics.nytimes.com:

Steroids came to weight lifting in Russia during the 1950s, and to America by 1960. By the end of the decade, other elite athletes had discovered the drugs. For nearly two decades, starting in the late 1960s, East German women dominated the international sports stage, aided by an organized system of anabolic steroid use. Despite strong testing procedures, steroid-related scandal has continued to follow the Olympic Games, the Tour de France and major professional sports.

Not all revelations of steroid use are accompanied by outrage. An admitted former user of steroids, Arnold Schwarzenegger, is governor of California. Professional wrestling, where steroid use has been widely documented, has been a ratings leader on cable television for years.

Like every other thing in this world, steroids can have bad effects but only when abused and the best way out is using them under medical guidance and for legal purposes.

If it is Bud Selig saying, it has to be true

Monday 01, Feb 2010

admin

if-it-is-bud-selig-saying-it-has-to-be-trueThe game of baseball has been kept under dark clouds after Mark McGwire made a belated confession of steroid use amidst crocodile tears and disclaimers. But Bud Selig thinks that the baseball steroid era is now over, a fact suggested by test results.

Though McGwire’s confession was not able to impress the die-hard baseball fans, it saved officials and team members by putting an end to the baseball’s era of performance-enhancing drugs to offer a new start for the game.

From Bostonherald.com:

That’s pretty much what Bud Selig said after the man who wouldn’t talk about the past to Congress finally spoke about it to Bob Costas. On the day of McGwire’s mea culpa, Selig said in a statement that in 2010, the use of steroids and amphetamines in baseball is “virtually nonexistent, as our testing results have shown.”

Two things: Either the commissioner of Major League Baseball pays no attention to the nonstop cat-and-mouse game still taking place between the International Olympic Committee and its world-class athletes, or he’s back to his old car-selling ways again.

If he ever really left them.

Otherwise, he would not have followed with this: “The so-called steroid era — a reference that is resented by the many players who played in that era and never touched the substances — is clearly a thing of the past, and Mark’s admission today is another step in the right direction.”

The steroid era might be a thing of the past in baseball. But performance-enhancing drugs are an ever-evolving industry, as the IOC and its testing agents long ago discovered. Simply stated, the cycle goes as follows: You design a testing program to detect all known performance-enhancing drugs. They design a new drug that escapes that detection. After a while, you get wise, develop even more encompassing detection. They take your test, and build a new PED that avoids that detection.

Selig remarked that the use of steroids and amphetamines is no more prevalent in the world of baseball.

Treating bronchiolitis with steroids is not a good option

Thursday 17, Dec 2009

admin

Treating bronchiolitis with steroids is not a good optionSteroid treatment is not an effective option for providing relief to infants with a common and potentially serious viral lower respiratory infection called bronchiolitis, as per a new study co-authored by Dr. Joan Bregstein of the Morgan Stanley Children’s Hospital of NewYork-Presbyterian and Columbia University Medical Center.

The study suggested that steroids do not help in preventing hospitalization or improve respiratory symptoms for bronchiolitis that is believed to be the common cause of hospitalization among infants.

From News-Medical.Net:

“Our study shows that treating bronchiolitis with steroids doesn’t work. We hope this study will resolve some of the uncertainty for physicians and families, as we move forward in developing better means of preventing and treating the infection,” says Dr. Bregstein, site principal investigator and emergency medicine pediatrician at Morgan Stanley Children’s Hospital of NewYork-Presbyterian and assistant clinical professor of pediatrics at Columbia University College of Physicians and Surgeons.

Current recommendations suggest that simple supportive care is the best available treatment for bronchiolitis. Researchers note that steroid-based medications still play an important role in other respiratory illnesses of childhood such as asthma and croup. They point out these medications are not the androgenic steroids sometimes abused by athletes, and that the side effects seen with long-term steroid use are not a risk in the short-course treatments used for croup and asthma attacks.

The multicenter study was published in the July 26 New England Journal of Medicine and conducted by the Pediatric Emergency Care Applied Research Network (PECARN).

It was highlighted that simply supportive care is the most effective option for bronchiolitis though steroid-based medications still play an important role in respiratory illnesses of childhood such as asthma and croup.

Incidence of rejection gets increased with early steroid withdrawal

Wednesday 02, Sep 2009

admin

Incidence of rejection gets increased with early steroid withdrawalA study indicated that a high incidence of rejection and a low incidence of intolerance is related to an early steroid withdrawal following liver transplantation. The study, which is hailed as the first-of-its-kind double-blind placebo-controlled study, was undertaken to examine effects of early steroid elimination.

The study results were published in an issue of Liver Transplantation, the official journal of the American Association for the Study of Liver Diseases (AASLD) and the International Liver Transplantation Society (ILTS).

From Eurekalert.org:

The normal course of treatment after liver transplantation includes calcineurin inhibitors (a class of immunosuppressants) and steroids to minimize rejection and improve survival rates, but the long-term complications of these drugs can be fatal. Steroid use in particular can lead to diabetes, high cholesterol and hypertension, which increase the risk of heart disease, and can lead to death. Several previous studies have reported that early withdrawal from steroids reduced the incidence of these side effects, but that rejection increased, although it could be controlled with steroid pulse therapy (in which high doses of steroids are administered intravenously for a short period of time). The current multicenter study was the first prospective double-blind, placebo-controlled trial to compare early steroid withdrawal with continued use.

Led by Georges-Philippe Pageaux, of the Centre Hospitalier University St.-Eloi in Montpellier, France, the study examined 174 patients in 15 French liver transplantation centers over a 14-month period from December 1999 to August 2001. The patients were randomly divided into two groups seven days following transplant: 90 of them continued to receive steroids for six months, while 84 received a placebo starting at day 14 (following 7 days of tapering from steroids). At the end of six months, 22 patients in the steroid group (24.4 percent) and 32 patients in the placebo group (38.1 percent) experienced acute rejection. Although there was no statistical difference in the two groups for high cholesterol and hypertension, 22.2 percent of patients in the steroid group developed diabetes compared with 14.3 percent of placebo patients. At the end of 12 months, the incidence of acute rejection was 25.6 percent in the steroid group versus 39.3 percent in the placebo group, but there no longer a difference in diabetes between the two groups.

The involved authors were of the view that early steroid withdrawal at day 14 cannot be termed as safe when it comes to rejection but told that it is efficient in terms of tolerability to glucose.

Sorry, no posts matched your criteria.